p53 Modulates Radiosensitivity in Head and Neck Cancers—From Classic to Future Horizons

p53, initially considered a tumor suppressor, has been the subject of research related to cancer treatment resistance in the last 30 years. The unfavorable response to multimodal therapy and the higher recurrence rate, despite an aggressive approach, make HNSCC a research topic of interest for impro...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diagnostics (Basel) Jg. 12; H. 12; S. 3052
Hauptverfasser:	Mireștean, Camil Ciprian, Iancu, Roxana Irina, Iancu, Dragoș Petru Teodor
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Switzerland MDPI AG 01.12.2022 MDPI
Schlagworte:	Apoptosis Biomarkers Cancer therapies Care and treatment Cell cycle Cell division Chemotherapy DNA damage Head & neck cancer Head and neck cancer head and neck cancers Health aspects HNSCC Kinases Metabolism Methods Mutation Ovarian cancer p53 Phase transitions Radiation radioresistance radiosensitivity Radiotherapy Review Tumor proteins Tumors Romania radiotherapy head and neck cancers HNSCC radioresistance radiosensitivity p53
ISSN:	2075-4418, 2075-4418
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!